The FDA needs to change the real way drug companies launch their new products. The explosion of fresh drugs to the market is an inherent threat to the general public and many more folks are at risk than in past years as no time appears to be allowed for these products to develop a background. The tools available to regulate prescription medication advertising are limited & lengthy to use. , drug companies argue adamantly that individuals gain important information from advertising. Previous FDA officials, declare the agency has the power it requires to shrink direct-to-consumer advertising & make sure that the promotion is in the public interest. Celebrex, Vioxx and Bextra special offers have all drawn FDA warnings.Using diagnostic photos and additional data from the Australian Blue Mountains Eye Study, the experts showed that patients who got abnormally narrow retinal arteries when the study began were also those that were most likely to possess glaucoma at its 10-year end point. If confirmed by future analysis, this finding could give ophthalmologists a fresh way to identify and treat those who are most vulnerable to vision reduction from glaucoma. The study was recently published on the web by Ophthalmology, the journal of the American Academy of Ophthalmology. Open-angle glaucoma , the most common type of the disease, affects three million people in the U nearly.S and 60 million worldwide.